Acino Pharma concludes agreement with Highnoon

29 Jan, 2011

Acino Pharma of Switzerland (www.acino-pharma.com), a company specialising in the development of advanced pharmaceutical formulations in the fields of oncology, acute pain management and palliative care, has concluded an agreement with Highnoon Laboratories Limited (www.highnoon-labs.com) to make available its product portfolio in Pakistan.
Highnoon Laboratories Limited is a leading marketer of high-quality prescription drugs in Pakistan manufacturing drugs under license for several world renowned companies for the last 26 years.
In Lahore this week was Salman Bokhari, Regional Director Asia Business for Acino Pharma Asia, who held detailed discussions with Chairman of Highnoon Laboratories Limited Tausif Ahmad Khan and the senior management to finalise arrangements to make available the Acino Pharma brands in Pakistan. Acino Pharma products, comprising high-quality brands of Swiss and European origin, are designed to help patients in need of specialised medicines at fair prices.-PR

Read Comments